218 related articles for article (PubMed ID: 2554875)
1. Studies on the mechanism of action of the bipyridine milrinone on the heart.
Farah AE; Frangakis CJ
Basic Res Cardiol; 1989; 84 Suppl 1():85-103. PubMed ID: 2554875
[TBL] [Abstract][Full Text] [Related]
2. The role of cyclic AMP and the dihydropyridine-sensitive channels on the mechanism of action of milrinone (Corotrope).
Frangakis CJ; Lanni C; Lasher KP; Bentley RG; Farah AE
J Cardiovasc Pharmacol; 1989 Jun; 13(6):915-24. PubMed ID: 2484087
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of the bipyridines: amrinone and milrinone.
Alousi AA; Johnson DC
Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
Fujino K; Sperelakis N; Solaro RJ
Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200
[TBL] [Abstract][Full Text] [Related]
5. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N; Blinks JR
Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
[TBL] [Abstract][Full Text] [Related]
6. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone.
Earl CQ; Linden J; Weglicki WB
J Cardiovasc Pharmacol; 1986; 8(4):864-72. PubMed ID: 2427830
[TBL] [Abstract][Full Text] [Related]
7. Effect of milrinone (Corotrope) on the contractility of isolated dog ventricular muscle.
Farah AE; Canniff PC; Bentley R; Kaiser LD
J Cardiovasc Pharmacol; 1987 Dec; 10(6):607-15. PubMed ID: 2450228
[TBL] [Abstract][Full Text] [Related]
8. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle.
Sys SU; Goenen MJ; Chalant CH; Brutsaert DL
Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
Satoh H; Endoh M
Jpn J Pharmacol; 1990 Feb; 52(2):215-24. PubMed ID: 2156096
[TBL] [Abstract][Full Text] [Related]
10. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M
Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663
[TBL] [Abstract][Full Text] [Related]
11. The effect of extracellular Ca2+ and related ions on the cardiac action of milrinone.
Farah AE; Canniff PC; Bentley RG; Frangakis CJ
J Cardiovasc Pharmacol; 1988 May; 11(5):591-600. PubMed ID: 2455846
[TBL] [Abstract][Full Text] [Related]
12. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Ahn HS; Eardley D; Watkins R; Prioli N
Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
[TBL] [Abstract][Full Text] [Related]
13. Decreased inotropic but relatively preserved relaxation response to cyclic adenosine monophosphate-dependent agents in myopathic human myocardium.
Gutstein DE; Flemmal K; Bruce E; Travers KE; Gwathmey JK; Ransil BJ; Markis JE; Grossman W; Morgan JP
J Card Fail; 1996 Dec; 2(4):285-92. PubMed ID: 8989643
[TBL] [Abstract][Full Text] [Related]
14. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria.
Muller B; Lugnier C; Stoclet JC
J Cardiovasc Pharmacol; 1990 Mar; 15(3):444-51. PubMed ID: 1691369
[TBL] [Abstract][Full Text] [Related]
15. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
[TBL] [Abstract][Full Text] [Related]
16. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB
J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-inhibiting properties of newer inotropic agents.
Scholz H; Meyer W
Circulation; 1986 Mar; 73(3 Pt 2):III99-108. PubMed ID: 2417748
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species.
Alousi AA; Stankus GP; Stuart JC; Walton LH
J Cardiovasc Pharmacol; 1983; 5(5):804-11. PubMed ID: 6195468
[TBL] [Abstract][Full Text] [Related]
20. The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret.
Gwathmey JK; Morgan JP
Br J Pharmacol; 1985 May; 85(1):97-108. PubMed ID: 2992656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]